✦ LIBER ✦

MAP (ERK-2) kinase — A key target for NSAID-induced inhibition of gastric cancer cell proliferation and growth

✍ Scribed by Husain, Syeda S.; Szabo, Imre L.; Pai, Rama; Soreghan, Brian A.; Tarnawski, Andrzej S.

Book ID: 124119048
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 190 KB
Volume: 120
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(08)83299-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

MAPK (ERK2) kinase—a key target for NSAI

MAPK (ERK2) kinase—a key target for NSAIDs-induced inhibition of gastric cancer cell proliferation and growth

✍ S.S. Husain; I.L. Szabo; R. Pai; B. Soreghan; M.K. Jones; A.S. Tarnawski 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 266 KB

Protein kinase C and adenylate cyclase a

Protein kinase C and adenylate cyclase as targets for growth inhibition of human gastric cancer cells

✍ Michael Piontek; Klaus-Jürgen Hengels; Rainer Porschen; Georg Strohmeyer 📂 Article 📅 1993 🏛 Springer-Verlag 🌐 English ⚖ 286 KB

Hypoxia inducible factor-1α is a key mol

Hypoxia inducible factor-1α is a key molecular target for NSAIDs inhibition of angiogenesis in rat gastric microvascular endothelial cells

✍ Jones, Michael K.; Szabo, Imre L.; Kawanaka, Hirofume; Sarfeh, I James; Tarnawsk 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 193 KB

The siRNA cocktail targeting VEGF and HE

The siRNA cocktail targeting VEGF and HER2 inhibition on the proliferation and induced apoptosis of gastric cancer cell

✍ Liu, Kun; Chen, Honglin; You, Qingsheng; Shi, Hai; Wang, Zhiwei 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 559 KB

Targeted inhibition of the epidermal gro

Targeted inhibition of the epidermal growth factor receptor-tyrosine kinase by ZD1839 (‘Iressa’) induces cell-cycle arrest and inhibits proliferation in prostate cancer cells

✍ Alessandro Sgambato; Andrea Camerini; Beatrice Faraglia; Raffaele Ardito; Gabrie 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 297 KB 👁 2 views

## Abstract The epidermal growth factor (EGF) plays a role in the development of prostate cancer, which becomes essential after androgen resistance has emerged. The EGF receptor (EGFR) is therefore a potential target for anticancer therapy. We evaluated the effects of ZD1839 (‘Iressa’), an orally a

Jacktruit Lectin (Jacalin), a Thomsen-Fr

Jacktruit Lectin (Jacalin), a Thomsen-Friedenreich antigen-binding lectin, inhibits proliferation of HT29 human colon cancer cells by altering cell surface tyrosine phosphorylation and down regulating MAP kinase kinase (MEK1/2) and MAP kinase (Erk1/2)

✍ Yu, Lu-Gang; Milton, Jeremy D.; Fernig, David G.; Rhodes, Jonathan M. 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 182 KB